The valves and what can go wrong
Four valves direct blood through the heart: aortic, mitral, tricuspid, and pulmonic. Each can develop stenosis (narrowing), regurgitation (leakage), or both. The most clinically important forms in adults:
Aortic stenosis
Narrowing of the aortic valve, most often from age-related calcification. The most common severe valve disease in adults. Classic symptoms: exertional breathlessness, chest pain, syncope. Severe symptomatic aortic stenosis benefits substantially from valve replacement — either transcatheter (TAVR) or surgical (SAVR). The TAVR option has expanded the population who can be treated, including patients previously considered too high-risk for surgery.
Mitral regurgitation
Leakage of the mitral valve. The most common mitral disorder. Two main causes: primary (the valve itself is abnormal — mitral valve prolapse, ruptured chord) and secondary (the valve is structurally normal but the geometry of the heart distorts its function, often from heart failure or AFib). Treatment depends on the type: primary severe regurgitation often benefits from mitral valve repair or replacement; secondary regurgitation benefits from treating the underlying heart failure first, with MitraClip or surgical intervention in selected cases.
Mitral stenosis
Less common in the US than it used to be (rheumatic disease has declined), but still seen. Causes left atrial enlargement, increased risk of AFib, and pulmonary congestion. Severe cases benefit from balloon mitral valvuloplasty or surgical intervention.
Aortic regurgitation
Leakage of the aortic valve. Often slowly progressive over years. Severe asymptomatic AR with left ventricular dilation or dysfunction benefits from valve replacement.
Tricuspid regurgitation
Common, especially in older adults with heart failure or pulmonary hypertension. Treatment used to be limited; new transcatheter therapies (TriClip, EVOQUE) have changed the landscape and severe symptomatic TR now has more options.
How valve disease is followed over time
The work is matching surveillance to severity:
- Mild disease — generally followed every 3-5 years with echo. No specific therapy needed; comorbidity management (BP, lipids).
- Moderate disease — every 1-2 years with echo; symptom check at each visit.
- Severe asymptomatic disease — every 6-12 months, sometimes more frequently. Watch for early symptoms and structural changes (LV size and function) that trigger intervention.
- Severe symptomatic disease — proceeds to intervention decision-making promptly.
What modern valve intervention looks like
Transcatheter approaches have dramatically expanded the population who can be treated:
- TAVR (transcatheter aortic valve replacement) — for aortic stenosis, increasingly first-line across risk categories.
- MitraClip / TEER (transcatheter edge-to-edge repair) — for select mitral regurgitation patients.
- TriClip / EVOQUE — for severe tricuspid regurgitation.
- Surgical valve repair or replacement — remains the right choice for many patients, particularly primary mitral disease where repair is feasible and durable.
The right procedure depends on the valve, the anatomy, the severity, the surgical risk, and the patient's preferences and life expectancy. A cardiologist familiar with the current landscape helps walk through the options.
How virtual cardiology handles valve disease
The longitudinal monitoring and decision-making work fits virtual cardiology well:
- First visit by video. History, review of prior echoes and records, classification of severity, plan for surveillance.
- Echoes ordered to imaging centers near you at the appropriate interval. Reviewed by your cardiologist.
- Follow-up visits by video to review imaging, assess symptoms, optimize medical therapy.
- Referral for intervention when criteria are met — to a procedure-equipped local cardiac center. Pre-procedure decision-making and post-procedure management coordinated virtually with the local intervention team.
Valve disease is also one of the conditions for which a cardiac second opinion is especially worth getting before any major procedure.